Unknown

Dataset Information

0

Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.


ABSTRACT: Background and purpose:Patient-level benefits of proton beam therapy (PBT) relative to photon therapy for prostate cancer (PC) continue to be the focus of debate. Although trials comparing the two modalities are underway, most are being conducted using "conventional" PBT (passive scattering/uniform scanning [PS/US]) rather than pencil beam scanning (PBS). The dosimetric benefits of PBS are well-known, but comparative data are limited. This analysis compares PBS toxicity rates with those of PS/US in a prospective multicenter registry. Methods:We evaluated acute/late gastrointestinal (GI) and genitourinary (GU) toxicity rates for men with low-to-intermediate risk PC enrolled in PCG 001-09. Acute toxicities with the two techniques were compared using ?2 tests, and the cumulative incidence methods for late toxicity. Multivariable analyses (MVAs) for acute toxicity were performed using logistic regression, and cox proportional hazards models for late toxicity. Results:Patients were treated using PS/US (n?=?1105) or PBS (n?=?238). Acute grade ?2 GI toxicity in PBS did not significantly differ from that with PS/US (2.9% and 2.1%, respectively; P?=?0.47). Acute grade ?2?GU toxicity was significantly higher with PBS (21.9% and 15.1%; P?

SUBMITTER: Mishra MV 

PROVIDER: S-EPMC6804653 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.

Mishra Mark V MV   Khairnar Rahul R   Bentzen Søren M SM   Larson Gary G   Tsai Henry H   Sinesi Christopher C   Vargas Carlos C   Laramore George G   Rossi Carl C   Rosen Lane L   Zhu Mingyao M   Hartsell William W  

Clinical and translational radiation oncology 20190831


<h4>Background and purpose</h4>Patient-level benefits of proton beam therapy (PBT) relative to photon therapy for prostate cancer (PC) continue to be the focus of debate. Although trials comparing the two modalities are underway, most are being conducted using "conventional" PBT (passive scattering/uniform scanning [PS/US]) rather than pencil beam scanning (PBS). The dosimetric benefits of PBS are well-known, but comparative data are limited. This analysis compares PBS toxicity rates with those  ...[more]

Similar Datasets

| S-EPMC6986399 | biostudies-literature
| S-EPMC8149965 | biostudies-literature
| S-EPMC8598136 | biostudies-literature
| S-EPMC7882114 | biostudies-literature